Transformative Psychiatric Researcher William Carpenter, MD, To Step Down as Editor-in-Chief of the University of Maryland School of Medicine's Maryland Psychiatric Research Center

The Maryland Psychiatric Research Center (MPRC), Department of Psychiatry, at the University of Maryland School of Medicine is the home of the prominent journal, the Schizophrenia Bulletin. After 18 years of leadership, William T. Carpenter, MD, Professor of Psychiatry and Pharmacology at UMSOM, is leaving his role as Editor-in-Chief (EIC) and will be replaced by James M. Gold, PhD, Professor of Psychiatry at UMSOM. He will assume leadership on July 1, 2023. His science has greatly advanced knowledge regarding psychopathology of schizophrenia and related disorders, and his recognition for original research relating to psychotic illness assures continued leadership for the premiere international journal devoted to psychiatry’s primary disorder.

Dr. Carpenter, the founding Director of the MPRC, along with other MPRC faculty, have played a significant role in the current success of this journal. Schizophrenia Bulletin was established in 1969 by Loren Mosher, MD and published by the National Institute for Mental Health (NIMH).  In 2004, with the elective ending of NIMH ownership, MPRC competed for the rights to the journal among many outstanding applications. MPRC was successful in bringing the journal to the School of Medicine as a joint ownership with Oxford University Press (OUP). Under Dr. Carpenter’s leadership as EIC, the Bulletin has dramatically increased its citations, submission rates and is widely regarded as the journal of record in matters relating to psychosis and related disorders.

About the University of Maryland School of Medicine

Now in its third century, the University of Maryland School of Medicine was chartered in 1807 as the first public medical school in the United States. It continues today as one of the fastest growing, top-tier biomedical research enterprises in the world -- with 46 academic departments, centers, institutes, and programs, and a faculty of more than 3,000 physicians, scientists, and allied health professionals, including members of the National Academy of Medicine and the National Academy of Sciences, and a distinguished two-time winner of the Albert E. Lasker Award in Medical Research. With an operating budget of more than $1.3 billion, the School of Medicine works closely in partnership with the University of Maryland Medical Center and Medical System to provide research-intensive, academic, and clinically based care for nearly 2 million patients each year. The School of Medicine has nearly $600 million in extramural funding, with most of its academic departments highly ranked among all medical schools in the nation in research funding. As one of the seven professional schools that make up the University of Maryland, Baltimore campus, the School of Medicine has a total population of nearly 9,000 faculty and staff, including 2,500 students, trainees, residents, and fellows. The combined School of Medicine and Medical System (“University of Maryland Medicine”) has an annual budget of over $6 billion and an economic impact of nearly $20 billion on the state and local community. The School of Medicine, which ranks as the 8th highest among public medical schools in research productivity (according to the Association of American Medical Colleges profile) is an innovator in translational medicine, with 606 active patents and 52 start-up companies. In the latest U.S. News & World Report ranking of the Best Medical Schools, published in 2021, the UM School of Medicine is ranked #9 among the 92 public medical schools in the U.S., and in the top 15 percent (#27) of all 192 public and private U.S. medical schools. The School of Medicine works locally, nationally, and globally, with research and treatment facilities in 36 countries around the world. Visit medschool.umaryland.edu